YJ9069
Product Specifications
Target
CDK
Applications
Cell Cycle
Additionnal Information
YJ9069 is a potent, selective and orally bioavailable PROTAC degrader of CDK12/CDK13. It inhibits proliferation in prostate cancer cells by inducing gene-length-dependent transcriptional elongation defects, leading to DNA damage, cell-cycle arrest, and significant tumor growth suppression in vivo.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
